Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Hoffmann, Linda S ^a   Schmidt, Peter M ^b   Keim, Yvonne ^a   Hoffmann, Carsten ^c   Schmidt, Harald H H W ^d   Stasch, Johannes Peter ^a,e  

^a Pharma Research Centre   (Germany)

^b CSIRO   (Australia)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4H 8 BROMO 1,2,4 OXADIAZOLO(3,4 D)BENZ(B)(1,4)OXAZIN 1 ONE; CINACIGUAT; GUANYLATE CYCLASE; HEME; OXAZINE DERIVATIVE; ROTENONE; UNCLASSIFIED DRUG; BENZOIC ACID DERIVATIVE; CELL RECEPTOR; CYCLIC GMP; CYSTEINE; ENZYME ACTIVATOR; FLUORESCENT DYE; NITRIC OXIDE; NS 2028; OXADIAZOLE DERIVATIVE; SOLUBLE GUANYLYL CYCLASE;

ARTICLE; CELL LABELING; CONTROLLED STUDY; ENERGY TRANSFER; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; MUTAGENESIS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROCESS OPTIMIZATION; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHO CELL; CRICETULUS; DRUG EFFECT; ENZYME ACTIVATION; FLUORESCENCE; GENETICS; HAMSTER; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MUTATION; OXIDATION REDUCTION REACTION; PROTEIN ENGINEERING; SPECTROFLUOROMETRY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BENZOIC ACIDS; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC GMP; CYSTEINE; ENZYME ACTIVATION; ENZYME ACTIVATORS; FLUORESCENCE; FLUORESCENT DYES; GUANYLATE CYCLASE; HEME; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NITRIC OXIDE; OXADIAZOLES; OXAZINES; OXIDATION-REDUCTION; PROTEIN ENGINEERING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; ROTENONE; SIGNAL TRANSDUCTION; SPECTROMETRY, FLUORESCENCE;

EID: 80051775172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023596     Document Type: Article

References (48)

1. Wedel B, Humbert P, Harteneck C, Foerster J, Malkewitz J, et al. (1994) Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci U S A 91: 2592-2596.
2. Ma X, Sayed N, Beuve A, van den Akker F, (2007) NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism. EMBO J 26: 578-588.
3. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, et al. (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375-414.
4. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F, (2003) Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res 93: 907-916.
5. Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, et al. (2006) NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5: 755-768.
6. Gladwin MT, (2006) Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome. J Clin Invest 116: 2330-2332.
7. Chirkov YY, Horowitz JD, (2007) Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier? Pharmacol Ther 116: 287-305.
8. Fritz BG, Hu X, Brailey JL, Berry RE, Walker FA, et al. (2011) Oxidation and Loss of Heme in Soluble Guanylyl Cyclase from Manduca Sexta. Biochemistry.
9. Schmidt PM, Schramm M, Schroder H, Wunder F, Stasch JP, (2004) Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase. J Biol Chem 279: 3025-3032.
10. Roy B, Mo E, Vernon J, Garthwaite J, (2008) Probing the presence of the ligand-binding haem in cellular nitric oxide receptors. Br J Pharmacol 153: 1495-1504.
11. Schmidt HH, Schmidt PM, Stasch JP, (2009) NO- and haem-independent soluble guanylate cyclase activators. Handb Exp Pharmacol 191: 309-339.
12. Stasch JP, Hobbs AJ, (2009) NO-independent, haem-dependent soluble guanylate cyclase stimulators. Handb Exp Pharmacol 191: 277-308.
13. Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, H SA, et al. (2006) Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest 116: 2552-2561.
14. Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, et al. (2002) NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol 136: 773-783.
15. Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Lapp H, Stasch JP, et al. (2007) Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure. Hypertension 49: 1128-1133.
16. Meurer S, Pioch S, Pabst T, Opitz N, Schmidt PM, et al. (2009) Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation. Circ Res 105: 33-41.
17. Hoffmann LS, Schmidt PM, Keim Y, Schaefer S, Schmidt HH, et al. (2009) Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation. Br J Pharmacol 157: 781-795.
18. Martin F, Baskaran P, Ma X, Dunten PW, Schaefer M, et al. (2010) Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase. J Biol Chem 285: 22651-22657.
19. Rothkegel C, Schmidt PM, Stoll F, Schroder H, Schmidt HH, et al. (2006) Identification of residues crucially involved in soluble guanylate cyclase activation. FEBS Lett 580: 4205-4213.
20. Wunder F, Stasch JP, Hutter J, Alonso-Alija C, Huser J, et al. (2005) A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway. Anal Biochem 339: 104-112.
21. Zhao Y, Brandish PE, DiValentin M, Schelvis JP, Babcock GT, et al. (2000) Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 39: 10848-10854.
22. Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, et al. (1998) Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br J Pharmacol 123: 299-309.
23. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, et al. (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278: 8516-8525.
24. Hobbs AJ, Stasch JP, (2009) Soluble guanylate cyclase: allosteric activation and redox regulation. In: Ignarro LJ, editors. Nitric Oxide: Biology and Pathobiology, second edition Burlington, MA, USA Academic Press pp. 301-326.
25. Nedvetsky PI, Meurer S, Opitz N, Nedvetskaya TY, Muller H, et al. (2008) Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclase. FEBS Lett 582: 327-331.
26. Ruetten H, Zabel U, Linz W, Schmidt HH, (1999) Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 85: 534-541.
27. Melichar VO, Behr-Roussel D, Zabel U, Uttenthal LO, Rodrigo J, et al. (2004) Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc Natl Acad Sci U S A 101: 16671-16676.
28. Kagota S, Tamashiro A, Yamaguchi Y, Sugiura R, Kuno T, et al. (2001) Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats. Br J Pharmacol 134: 737-744.
29. Nikolaev VO, Lohse MJ, (2009) Novel techniques for real-time monitoring of cGMP in living cells. Handb Exp Pharmacol 191: 229-243.
30. Kosarikov DN, Lee JM, Uversky VN, Counts Gerber N, (2001) Role of conformational changes in the heme-dependent regulation of human soluble guanylate cyclase. J Inorg Biochem 87: 267-276.
31. Yantsevich AV, Harnostai IN, Lukashevich OP, Gilep AA, Usanov SA, (2007) Engineering, expression, purification, and physicochemical characterization of a chimeric protein, full-length cytochrome b(5)-green fluorescence protein (HMWb5-EGFP). Biochemistry (Mosc) 72: 77-83.
32. Lepesheva GI, Strushkevich NV, Usanov SA, (1999) Conformational dynamics and molecular interaction reactions of recombinant cytochrome p450scc (CYP11A1) detected by fluorescence energy transfer. Biochim Biophys Acta 1434: 31-43.
33. Griffin BA, Adams SR, Tsien RY, (1998) Specific covalent labeling of recombinant protein molecules inside live cells. Science 281: 269-272.
34. Adams SR, Campbell RE, Gross LA, Martin BR, Walkup GK, et al. (2002) New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc 124: 6063-6076.
35. Hoffmann C, Gaietta G, Bunemann M, Adams SR, Oberdorff-Maass S, et al. (2005) A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat Methods 2: 171-176.
36. Zhang J, Campbell RE, Ting AY, Tsien RY, (2002) Creating new fluorescent probes for cell biology. Nat Rev Mol Cell Biol 3: 906-918.
37. Estevez JM, Somerville C, (2006) FlAsH-based live-cell fluorescent imaging of synthetic peptides expressed in Arabidopsis and tobacco. Biotechniques 41: 569 570 572-564.
38. Gaietta GM, Giepmans BN, Deerinck TJ, Smith WB, Ngan L, et al. (2006) Golgi twins in late mitosis revealed by genetically encoded tags for live cell imaging and correlated electron microscopy. Proc Natl Acad Sci U S A 103: 17777-17782.
39. Liu R, Hu D, Tan X, Lu HP, (2006) Revealing two-state protein-protein interactions of calmodulin by single-molecule spectroscopy. J Am Chem Soc 128: 10034-10042.
40. Luedtke NW, Dexter RJ, Fried DB, Schepartz A, (2007) Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH. Nat Chem Biol 3: 779-784.
41. Zurn A, Zabel U, Vilardaga JP, Schindelin H, Lohse MJ, et al. (2009) Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes. Mol Pharmacol 75: 534-541.
42. Takeda S, Kamiya N, Arai R, Nagamune T, (2001) Design of an artificial light-harvesting unit by protein engineering: cytochrome b(562)-green fluorescent Protein chimera. Biochem Biophys Res Commun 289: 299-304.
43. Kuznetsova S, Zauner G, Schmauder R, Mayboroda OA, Deelder AM, et al. (2006) A Forster-resonance-energy transfer-based method for fluorescence detection of the protein redox state. Anal Biochem 350: 52-60.
44. Davydov DR, Davydova NY, Halpert JR, (2008) Allosteric transitions in cytochrome P450eryF explored with pressure-perturbation spectroscopy, lifetime FRET, and a novel fluorescent substrate, Fluorol-7GA. Biochemistry 47: 11348-11359.
45. Baird GS, Zacharias DA, Tsien RY, (2000) Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc Natl Acad Sci U S A 97: 11984-11989.
46. Straub A, Benet-Buckholz J, Frode R, Kern A, Kohlsdorfer C, et al. (2002) Metabolites of orally active NO-independent pyrazolopyridine stimulators of soluble guanylate cyclase. Bioorg Med Chem 10: 1711-1717.
47. Hoffmann C, Gaietta G, Zurn A, Adams SR, Terrillon S, et al. (2010) Fluorescent labeling of tetracysteine-tagged proteins in intact cells. Nat Protoc 5: 1666-1677.
48. Rothkegel C, Schmidt PM, Atkins DJ, Hoffmann LS, Schmidt HH, et al. (2007) Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo. Mol Pharmacol 72: 1181-1190.